Browsing by Author "Apostolopoulos, Vasso"

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Global Mpox outbreak: Are we prepared for emerging strains?
    (Elsevier, 2024-08-23) Sah, Ranjit; Srivastava, Shriyansh; Mehta, Rachana; Kumar, Sachin; Sah, Sanjit; Mohanty, Aroop; Feehan , Jack; Al-Tawfiq, Jaffar A.; Apostolopoulos, Vasso; Medicine, School of Medicine
  • Thumbnail Image
    Item
    New antibiotics targeting Gram-negative bacilli
    (Department of Medicine and Surgery, University of Salerno, 2025-03-01) Al-Tawfiq, Jaffar A.; Sah, Ranjit; Mehta, Rachana; Apostolopoulos, Vasso; Temsah, Mohamad-Hani; Eljaaly, Khalid; Medicine, School of Medicine
    Antimicrobial resistance (AMR) is an emerging global threat. It increases mortality and morbidity rates and places a heavy burden on healthcare systems. Healthcare professionals can address the increasing issue of AMR by advocating responsible antibiotic use and supporting the development of new medications. Despite the economic, logistic, and scientific challenges, it is reassuring that new agents continue to be developed. This review addresses new antibiotics in the pipeline. A review of the literature was conducted including Medline, and Clinicaltrials.org, for approved and in pipeline antibiotics in phase 3 or new drug applications (NDA). We found several new antibiotics and reviewed their current development status, mode of action, spectra of activity, and indications for which they have been approved. The included studies from phase 3 clinical trials were mainly utilized for the treatment of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and pneumonia acquired in healthcare settings. The availability of these agents is limited for high-priority organisms. The identified antibiotics were primarily based on previously known molecules or pre-existing antimicrobial agents. There is a limited number of antibiotics against high priority organisms. New antimicrobial agents targeting the top-priority organisms identified by the World Health Organization are urgently needed. However, some antibiotics target ESBL-producing Enterobacterales, carbapenem-resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa.
  • Thumbnail Image
    Item
    Re-emergence of Chandipura virus in India: Urgent need for public health vigilance and proactive management
    (Elsevier, 2024-10-10) Pareek, Ashutosh; Singhal, Runjhun; Pareek, Aaushi; Chuturgoon, Anil; Sah, Ranjit; Mehta, Rachana; Al-Tawfiq, Jaffar A.; Apostolopoulos, Vasso; Medicine, School of Medicine
  • Thumbnail Image
    Item
    Urgent call for vaccine supply to Africa amid ongoing Mpox clade I outbreak: addressing a public health emergency of international concern
    (Sage, 2024-10-27) Feehan, Jack; Sah, Ranjit; Mehta, Rachana; Byanga, Kahumba; Anand, Krishnan; Krsak, Martin; Al-Tawfiq, Jaffar A.; Henao-Martínez, Andrés F.; Apostolopoulos, Vasso; Medicine, School of Medicine